Advertisement
News
Subscribe to MDT Magazine News

Clinical Data depression drug gets FDA approval

January 24, 2011 11:43 am | by Mass High Tech: The Journal of New England Technology | Comments

Newton drug developer Clinical Data Inc. has received U.S. Food and Drug Administration approval for its vilazodone HCl tablets to treat adults with major depressive disorder (MDD).

Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online

January 24, 2011 11:36 am | by Bio-Medicine.Org | Comments

CLEVELAND, Jan. 24, 2011 /- Athersys, Inc. (Nasdaq: ATHX ), a clinical stage biopharmaceutical company, today announced that its January 11th Retail Investor Conferences.com presentation is available for on-demand viewing.  Gil Van Bokkelen, PhD, Chairman and Chief Executive Officer...

TOPICS:

Study examines earlier use of heart pumps in growing group of heart failure patients

January 24, 2011 11:34 am | by EurekAlert | Comments

(University of Michigan Health System) The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the large and growing group of Americans with heart failure. The NIH and...

TOPICS:
Advertisement

Mylan's Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets

January 24, 2011 11:34 am | by Bio-Medicine.Org | Comments

PITTSBURGH, Jan. 24, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-release (DR)...

TOPICS:

Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine

January 24, 2011 11:34 am | by Bio-Medicine.Org | Comments

WASHINGTON, Jan. 24, 2011 /PRNewswire-USNewswire/ -- More than 300 million Americans get the common cold, and up to 70 million get the flu annually. But for the 60 million people who also have asthma and allergies, a cold or flu can pose even greater risks. Together, these respiratory...

TOPICS:

Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive

January 24, 2011 11:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 24, 2011 /- Genelux Corporation, a privately held, clinical stage biopharmaceutical company developing diagnostic and therapeutic solutions for cancer and inflammatory diseases, today announced the appointment of Dr. Dennis Fenton, long-time Amgen executive, to the...

TOPICS:

Not Resting on Its Laurels, Startup Focusing on Sleep Disorders

January 24, 2011 8:32 am | by San Diego Business Journal | Comments

With business partners such as Roche and Stanford University already on board to test its wireless brain recording technology, NeuroVigil Inc. is looking to make some other smart moves in 2011.

TOPICS:

Materials for the January 26, 2011 Circulatory System Devices Panel Meeting

January 24, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

Added FDA generated and non-FDA generated materials.

TOPICS:
Advertisement

Introduction of TomoTherapy Treatments at New Ballard, Wash. Facility Delivers Flexibility in Treating Wide Range of Cancers

January 24, 2011 7:45 am | by The Associated Press | Comments

http://www.tomotherapy.com () —TomoTherapy Incorporated (http://www.tomotherapy.com/) (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that Swedish Cancer Institute (SCI)...

Cutting Edge Nanotech Patents for Displays, Lighting, X-ray, Medical Imaging, and Diagnostics Available for Sale by ICAP Ocean Tomo

January 24, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHICAGO, Jan. 24, 2011 /- ICAP Ocean Tomo , the intellectual property brokerage division of ICAP plc (IAP.L) and the world's premier patent auction firm, announces the sale of x-ray imaging patents from renowned inventor Till Keesmann. Consisting of seven issued patents and seven related...

TOPICS:

Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America

January 24, 2011 5:34 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Jan. 24, 2011 /- Based on its recent analysis of the personal emergency response systems (PERS) market, Frost & Sullivan recognizes BeClose with the 2010 North American Frost & Sullivan Award for Technology Innovation of the Year for its innovative BeClose...

TOPICS:

BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal

January 24, 2011 5:34 am | by Bio-Medicine.Org | Comments

FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 24, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, and Rady Children's Hospital-San Diego today announced that they have implemented an innovative pilot program at the Hospital that is designed...

TOPICS:

High Tech Vet Medical Warming System Introduced at Orlando

January 24, 2011 5:34 am | by Bio-Medicine.Org | Comments

LAKE OSWEGO, Ore., Jan. 24, 2011 /- Lake Oswego, Oregon based ThermoGear, Inc., partnered with DVM Solutions, San Antonio, Texas, have announced the rollout of a new high technology veterinary surgical system that took place at the recent North American Veterinary Conference in Orlando,...

TOPICS:

NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein

January 24, 2011 5:34 am | by Bio-Medicine.Org | Comments

LAWRENCE, Mass., Jan. 24, 2011 /- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced the addition of Nancy J. Ham to the Company's Board of Directors and the resignation of Jonathan T. Silverstein. Mr. Silverstein, General...

TOPICS:

NovaMed shareholder protests proposed acquisition

January 24, 2011 4:45 am | by The Associated Press | Comments

A NovaMed Inc. shareholder has asked the ambulatory surgery center operator to reconsider a planned acquisition by a private equity firm for $13.25 per share.Noble Equity Capital Management said Monday a planned deal with H.I.G. Capital affiliate Surgery Partners "does not sufficiently reward...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading